Objective:To systematically review the safety of different types of chikungunya vaccines in human populations.Methods:This study retrieved randomized controlled trials(RCTs)reporting on the safety of chikungunya vacci...Objective:To systematically review the safety of different types of chikungunya vaccines in human populations.Methods:This study retrieved randomized controlled trials(RCTs)reporting on the safety of chikungunya vaccines in human populations through electronic searches of the Web of Science,PubMed,EMbase,and Cochrane Library databases.Two reviewers independently performed literature screening,data extraction,and risk of bias assessment for the included studies.Meta-analysis was conducted using STATA 18.0 software.Results:A total of eight RCTs involving 9336 subjects were included in this study.Meta-analysis showed that three out of the five chikungunya vaccines(VLA1553,mRNA-1388,and PXVX0317)exhibited favorable safety profiles,with no significant increase in the incidence of serious adverse events.The vaccine group had a higher incidence of any adverse events[risk ratio(RR)=1.26,P<0.001]and any systemic adverse events(RR=1.18,P=0.010)compared to the placebo group.The incidence of local adverse events was also higher in the vaccine group(RR=2.09,P<0.001).However,there were no significant differences between the two groups in the incidences of erythema(RR=1.41,P=0.402),headache(RR=1.14,P=0.457),or arthralgia(RR=1.45,P=0.660).Conclusions:Current evidence supports that chikungunya vaccines have a favorable safety profile.However,due to limitations in the number and quality of included studies,further high-quality research is needed to validate these conclusions.展开更多
Chikungunya virus(CHIKV)infection in humans causing severe musculoskeletal pain,fever and rashes,is transmitted by the bite of infected mosquitoes,primarily Aedes(Ae.)aegypti and Ae.albopictus.CHIKV has resulted in 18...Chikungunya virus(CHIKV)infection in humans causing severe musculoskeletal pain,fever and rashes,is transmitted by the bite of infected mosquitoes,primarily Aedes(Ae.)aegypti and Ae.albopictus.CHIKV has resulted in 18.7 million cases worldwide till 2020 and after 2004 has spread to Europe,Middle East(Saudi Arabia,Pakistan,Yemen,Egypt,Oman,Iraq,Kuwait,and Iran)and Pacific regions.This rapid spread of CHIKV emphasizes the pivotal need of enforcing control measures and examining new diagnostic methods.As the mosquito vectors(Aedes)of CHIKV are evolving,vector control methods are losing its efficacy.Further,existing serological and molecular assays to detect CHIKV show variabilities in sensitivity and specificity,leading to mis-reporting or under-reporting of CHIKV cases in affected regions.In this review article,we start by discussing CHIKV infection,followed by an introduction to currently available control and detection methods.We further highlight the challenges these methods pose and how they can be conquered by employing various easy and sustainable strategies.This review may provide valuable information for the development of novel diagnostic strategies in resource limited settings for mitigating CHIKV disease.展开更多
Chikungunya,a vector-borne viral disease,has become a critical global health issue due to its capacity for widespread outbreaks,especially in tropical and subtropical regions,and its recent global expansion.The resurg...Chikungunya,a vector-borne viral disease,has become a critical global health issue due to its capacity for widespread outbreaks,especially in tropical and subtropical regions,and its recent global expansion.The resurgence of Chikun-gunya virus(CHIKV)in Karachi,Pakistan,has amplified public health challen-ges,driven by factors such as urbanization,climate change,and socioeconomic vulnerabilities,including limited healthcare infrastructure.Clinically,the disease primarily manifests with fever,rash,and debilitating joint pain,which often leads to prolonged discomfort and decreased quality of life.However,emerging evi-dence points to atypical and severe complications affecting the neurological,cardiac,and kidney systems,increasing the risk of mor-bidity and mortality.Kidney involvement in Chikungunya is of particular concern,with acute kidney injury being identified as a critical complication.Timely diagnosis of the infection and early identification of individuals at heigh-tened risk of progressing to severe kidney dysfunction is crucial to improving patient outcomes.Such individuals often include those with pre-existing kidney conditions or other underlying comorbidities,making them more susceptible to complications.This narrative review aims to synthesize and expand upon the current understanding of the me-chanisms underlying CHIKV-induced kidney injury.These mechanisms en-compass direct viral invasion of kidney tissue,immune-mediated inflammatory responses that inadvertently damage the kidneys,and the aggravation of pre-existing kidney pathologies.Furthermore,the complex interplay between the virus and the host's immune system may exacerbate kidney complications,high-lighting the multifaceted nature of CHIKV pathophysiology.展开更多
Chikungunya is a mosquito-borne viral infection caused by the chikungunya virus(CHIKV).It is characterized by acute onset of high fever,severe polyarthralgia,myalgia,headache,and maculopapular rash.The virus is rapidl...Chikungunya is a mosquito-borne viral infection caused by the chikungunya virus(CHIKV).It is characterized by acute onset of high fever,severe polyarthralgia,myalgia,headache,and maculopapular rash.The virus is rapidly spreading and may establish in new regions where competent mosquito vectors are present.This research analyzes the regulatory dynamics of a stochastic differential equation(SDE)model describing the transmission of the CHIKV,incorporating seasonal variations,immunization efforts,and environmentalffuctuations modeled through Poisson random measure noise under demographic heterogeneity.The model guarantees the existence of a global positive solution and demonstrates periodic dynamics driven by environmental factors.A key contribution of this study is the formulation of a stochastic threshold parameter,R0L,which characterizes the conditions for disease persistence or extinction under random environmental inffuences.Although our analysis highlights age-speciffc heterogeneities to illustrate differential transmission risks,the framework is general and can incorporate other vulnerable demographic groups,ensuring broader applicability of the results.Using the Monte Carlo Markov Chain(MCMC)method,we estimate R0L=1.4978(95%C-I:1.4968–1.5823)based on CHIKV data from Florida,USA,spanning 2005 to 2017,suggesting that the outbreak remains active and requires targeted control strategies.The effectiveness of immunization,screening,and treatment strategies varies depending on the prioritized demographic groups,due to substantial differences in CHIKV incidence across age categories in the USA.Numerical simulations were conducted using the truncated Euler–Maruyama method to robustly capture the stochastic dynamics of CHIKV transmission with Poissondriven jumps.Employing an iterative approach and assuming mild convexity conditions,we formulated and solved a parameterized near-optimality problem using the Ekeland variational principle.Ourffndings indicate that vaccination campaigns are signiffcantly more effective when focused on vulnerable adults over the age of 66,as well as individuals aged 21 to 25.Furthermore,enhancements in vaccine effcacy,diagnostic screening,and treatment protocols all contribute substantially to minimizing infection rates compared to current standard approaches.These insights support the development of targeted,age-speciffc public health interventions that can signiffcantly improve the management and control of future CHIKV outbreaks.展开更多
Rationale:Parsonage-Turner syndrome is a rare syndrome of unknown etiology,affecting mainly the lower motor neurons of the brachial plexus.Chikungunya fever is a mosquito-borne viral disease characterized by acute fev...Rationale:Parsonage-Turner syndrome is a rare syndrome of unknown etiology,affecting mainly the lower motor neurons of the brachial plexus.Chikungunya fever is a mosquito-borne viral disease characterized by acute fever and polyarthritis/polyarthralgia.Patient concerns:A 54-year-old Brazilian male patient who presented with a 2-day history of fever(temperature 38.8℃),arthralgia,erythematous rash,diffuse osteomuscular pain and headache,which evolved into left shoulder pain associated with morning stiffness.Diagnosis:Parsonage-Turner syndrome and chikungunya fever.Interventions:Symptomatic treatment(a combination of short-acting dypirone(500 mg every 6 h)and slow-release opioids(tramadol 100 mg every 4 h)and physiotherapy/rehabilitation with improvement.Outcomes:The patient was improved and discharged,remaining with symptomatic treatment and physiotherapy/rehabilitation.Lessons:To the best of our knowledge,there were no reports of Parsonage-Turner syndrome following chikungunya virus infection.Awareness of the possibility of this rare association is important.The present case report highlights the importance of awareness of this association as a new cause of morbidity in patients with chikungunya virus infection.展开更多
Objective:To obtain Iuteolin and apigenin rich fraction from the ethanolic extract of Cynodon dactylon(L.)(C.dactylon) Pers and evaluate the fraction's cytotoxicity and anti-Chikungunya potential using Vero cells....Objective:To obtain Iuteolin and apigenin rich fraction from the ethanolic extract of Cynodon dactylon(L.)(C.dactylon) Pers and evaluate the fraction's cytotoxicity and anti-Chikungunya potential using Vero cells.Methods:The ethanolic extract of C.dactylon was subjected to silica gel column chromatography to obtain anti-chikungunya virus(CHIKV) fraction.Reverse phase-HPLC and GC-MS studies were carried out to identily the major phytochemicals in the fraction using phylochemical standards.Cytotoxicity and the potential of the fraction against CHIKV were evaluated in vitro using Vero cells.Reduction in viral replication was assessed by reverse transcriptase-polymerase chain reaction(RT-PCR) after treating the viral infected Vero cells with the fraction.Results:Reverse Phase-HPLC and GC-MS studies confirmed the presence of flavonoids,luteolin and apigenin as major phytochemicals in the anti-CHIKV ethanolic fraction of C.dactylon- The fraction was found to exhibit potent viral inhibitory activity(about 98%) at the concentration of 50 μg/mL as observed by reduction in cytopathic effect,and the cytotoxic concentration of the fraction was found to be 250 μg/mL.RT-PCR analyses indicated that the reduction in viral mRNA synthesis in fraction treated infected cells was much higher than the viral infected control cells.Conclusions:Luteolin and apigenin rich ethanolic fraction from C.dactylon can be utilized as a potential therapeutic agent against CHIKV infection as the fraction does not show cytotoxicity while inhibiting the virus.展开更多
Infectious diseases are indeed a lifelong threat to everyone irrespective of age, sex, lifestyle and socio-economic status. The infectious diseases have persisted among the prominent causes of death globally. Recently...Infectious diseases are indeed a lifelong threat to everyone irrespective of age, sex, lifestyle and socio-economic status. The infectious diseases have persisted among the prominent causes of death globally. Recently, re-emergence of Chikungunya viral infection harmed many in Asian and African countries. Chikungunya was considered as a major threat in developing and underdeveloped countries; the recent epidemiological outbreak of Chikungunya in La Reunion urges the global researchers to develop effective vaccine against this viral disease. In this review, Chikungunya, pathogenesis and epidemiology were briefly described.展开更多
Objective:To develop diagnostic test for detection chikungunya virus(CHIKV and Dengue virus (DENV) infection.Methods:We have performed a rapid,accurate laboratory confirmative method to simultaneously detect,quantify ...Objective:To develop diagnostic test for detection chikungunya virus(CHIKV and Dengue virus (DENV) infection.Methods:We have performed a rapid,accurate laboratory confirmative method to simultaneously detect,quantify and differentiate CHIKV and DENV infection by single-step multiplex real-time RT-PCR.Results:The assay’s sensitivity was 97.65%,specificity was 92.59% and accuracy was 95.82%when compared to conventional RT-PCR.Additionally,there was no cross-reaction between CHIKV,DENV,Japanese encephalitis virus,hepatitis C,hepatitis A or hepatitis E virus.Conclusions:This rapid and reliable assay provides a means for simultaneous early diagnosis of CHIKV and DENV in a single-step reaction.展开更多
Chikungunya virus(CHIKV) is an arbovirus transmitted by Aedes mosquitos in tropical and subtropical regions across the world. After decades of sporadic outbreaks, it re-emerged in Africa,Asia, India Ocean and America ...Chikungunya virus(CHIKV) is an arbovirus transmitted by Aedes mosquitos in tropical and subtropical regions across the world. After decades of sporadic outbreaks, it re-emerged in Africa,Asia, India Ocean and America suddenly, causing major regional epidemics recently and becoming a notable global health problem. Infection by CHIKV results in a spectrum of clinical diseases including an acute self-limiting febrile illness in most individuals, a chronic phase of recurrent join pain in a proportion of patients, and long-term arthralgia for months to years for the unfortunate few. No specific anti-viral drugs or licensed vaccines for CHIKV are available so far. A better understanding of virus-host interactions is essential for the development of therapeutics and vaccines. To this end, we reviewed the existing knowledge on CHIKV's epidemiology, clinical presentation, molecular virology, diagnostic approaches, host immune response, vaccine development, and available animal models. Such a comprehensive overview, we believe, will shed lights on the promises and challenges in CHIKV vaccine development.展开更多
Objective:To investigate the efficacy of ethanolic extract of nilavembu kudineer choornam (EENKC) in inflammation,pain and fever using animal models to support its actions.Methods: Acute toxicity study of EENKC was pe...Objective:To investigate the efficacy of ethanolic extract of nilavembu kudineer choornam (EENKC) in inflammation,pain and fever using animal models to support its actions.Methods: Acute toxicity study of EENKC was performed in mice to fix the effective dose.The antipyretic, anti-inflammatory and analgesic activity of EENKC was evaluated in brewer’s yeast induced pyrexia in rats,carrageenan-induced inflammation in rats and acetic-acid induced writhing in mice model.Results:Acute toxicity revealed that EENKC didn’t show death and toxic signs up to 2 000 mg/kg.In brewer’s yeast induced pyrexia and carrageenan-induced inflammation EENKC at the doses of 200 and 400 mg/kg inhibited fever and inflammation significantly(P【0.01 and【0.05) compared to control animals.In mice,the number of writhing induced by acetic-acid was significantly(P【0.01) reduced after treatment with both the dose of EENKC than control animals. EENKC 200 mg/kg inhibits inflammation higher level in carrageenan-induced paw edema,but there is no significant difference when compared to indomethacin 10 mg/kg.Conclusions:The present findings revealed that EENKC possesses antipyretic,anti-inflammatory and analgesic activity which supports nilavembu kudineer choornam efficacy in chikungunya fever.展开更多
Chikungunya fever is a vector-borne viral disease transmitted to humans by chikungunya virus(CHIKV)-infected mosquitoes.There have been many outbreaks of CHIKV infection worldwide,and the virus poses ongoing risks to ...Chikungunya fever is a vector-borne viral disease transmitted to humans by chikungunya virus(CHIKV)-infected mosquitoes.There have been many outbreaks of CHIKV infection worldwide,and the virus poses ongoing risks to global health.To prevent and control CHIKV infection,it is important to improve the current CHIKV diagnostic approaches to allow for the detection of low CHIKV concentrations and to correctly distinguish CHIKV infections from those due to other mosquito-transmitted viruses,including dengue virus(DENV),Japanese encephalitis virus(JEV),and Zika virus(ZIKV).Here,we produced monoclonal antibodies(mAbs)against the CHIKV envelope 2 protein(CHIKV-E2)and compared their sensitivity and specificity with commercially available mAbs using enzyme-linked immunosorbent assays(ELISA).Two anti-CHIKV-E2 mAbs,19-1 and 21-1,showed higher binding affinities to CHIKV-E2 protein than the commercial mAbs did.In particular,the 19-1 mAb had the strongest binding affinity to inactivated CHIKV.Moreover,the 19-1 mAb had very little cross-reactivity with other mosquito-borne viruses,such as ZIKV,JEV,and DENV.These results suggest that the newly produced anti-CHIKV-E2 mAb,19-1,could he used for CHIKV diagnostic approaches.展开更多
Chikungunya virus(CHIKV) is a mosquito-borne virus that causes epidemics widely in the world especially in the tropical and subtropical regions. Phylogenetic analysis has found that the CHIKV lineages were associated ...Chikungunya virus(CHIKV) is a mosquito-borne virus that causes epidemics widely in the world especially in the tropical and subtropical regions. Phylogenetic analysis has found that the CHIKV lineages were associated with the spatial and temporal distributions, which were related to the virus adaption to the major mosquito species and their distributions. In this study, we reported the complete genome sequences of eight CHIKV isolates from the outbreak in Pakistan last year. Then we reviewed the evolutionary history using extensive phylogenetic analysis, analyzed lineagespecific substitutions in viral proteins, and characterized the spreading pathway of CHIKV strains including the Pakistani strains. The results showed that the Pakistani stains belonged to the ECSA.IOL sub-lineage and derived from India. The genetic properties of the Pakistani strains including the adaptive substitution to vectors were further characterized, and the potential risks from the occurrence of CHIKV infection in Pakistan were discussed. These results provided better understanding of CHIKV evolution and transmission in the world and revealed the possible origination of the CHIKV outbreak and epidemic in Pakistan, which would promote the disease prevention and control in the identified countries and territories with the history of CHIKV infections as well as new regions with potential risk of CHIKV outbreaks.展开更多
Objective: To investigate cytokine profile in patients with chikungunya virus (CHIKV) infection. Methods: Twenty eight pairs of serum samples collected from CHIKV infected patients during the outbreak of chikungunya f...Objective: To investigate cytokine profile in patients with chikungunya virus (CHIKV) infection. Methods: Twenty eight pairs of serum samples collected from CHIKV infected patients during the outbreak of chikungunya fever in South Thailand in 2008 were obtained. A multiple cytokine assay for detection of 17 cytokines was performed. Results: In the acute stage of CHIKV infection, the patients had significantly higher levels of interleukin-6, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, monocyte chemotactic protein 1 and tumor necrosis factor alpha than the control ( P<0.001, P=0.023, P=0.015, P <0.001 and P=0.024, respectively). When the disease developed to the recovery stage, the patients had significantly lower levels of interleukin-6, granulocyte-macrophage colony-stimulating factor, monocyte chemotactic protein 1 and macrophage inflammatory protein beta than in the acute stage ( P<0.001). Conclusions: This study provides additional information that these cytokines could play roles in pathogenesis of CHIKV infection and could be used as disease biomarkers or drug targets.展开更多
Objective: To investigate the association between TLR3 and TLR7 polymorphisms with susceptibility and clinical manifestations of Chikungunya Fever.Methods: A total of 177 individuals were studied: 73 patients with a c...Objective: To investigate the association between TLR3 and TLR7 polymorphisms with susceptibility and clinical manifestations of Chikungunya Fever.Methods: A total of 177 individuals were studied: 73 patients with a confirmed diagnosis for Chikungunya virus and 104 non-infected individuals. Polymorphisms were determined by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism(PCR-RFLP).Results: Our analysis showed an increased CC genotype frequency of the TLR7 rs3853839 polymorphism in male patients compared to control(29% versus 2%,respectively; OR=20.69; 95% CI=2.55-167.36; P<0.001). Furthermore,arthritis(acute and chronic) was frequently found in CC male patients. On the contrary,65% of CG carriers were no-infected males(29% versus 65%,respectively; OR=0.23,95% CI=0.48-3.04; P=0.002). Finally,we observed a higher frequency of lymphopenia in CG male patients(CG=666.86±233.77,GG=1,314.27±752.29 cells/mm3,P=0.047). Conclusions: Our results suggest the TLR7 rs3853839 polymorphism is associated with lymphopenia and increased susceptibility to Chikungunya Fever in males.展开更多
A number of re-emerging and emerging infectious diseases including chikungunya, West Nile, yellow fever, Zika, dengue, Japanese encephalitis, and others have increased in recent years, which threaten the public health...A number of re-emerging and emerging infectious diseases including chikungunya, West Nile, yellow fever, Zika, dengue, Japanese encephalitis, and others have increased in recent years, which threaten the public health across the globe. Chikungunya is a neglected re-emerging arboviral infection caused by chikungunya virus. Arboviral infections such as chikungunya, Zika and dengue have similar epidemiology, transmission cycles and clinical symptoms, which makes it difficult to diagnose these three infections. Moreover, there is no commercial vaccine or licensed therapy available for chikungunya infection, thus causing severe burden worldwide. Vector control may reduce the disease risk; however, this remains a challenge due to many factors including, but not limited to, evolution of insecticide resistance in mosquitoes, gaps in vector control tools, urbanization, environmental and demographic changes. Effective integrated vector control strategies and surveillance measures along with affordable vaccine development or anti-viral therapy are essential to control the infection. In this review, we discuss the epidemiology of mosquito-borne infection chikungunya which has re-emerged as an international concern in recent decades.展开更多
Arthropod-borne chikungunya virus(CHIKV)infection can cause a debilitating arthritic disease in human.However,there are no specific antiviral drugs and effective licensed vaccines against CHIKV available for clinical ...Arthropod-borne chikungunya virus(CHIKV)infection can cause a debilitating arthritic disease in human.However,there are no specific antiviral drugs and effective licensed vaccines against CHIKV available for clinical use.Here,we developed an m RNA-lipid nanoparticle(m RNA-LNP)vaccine expressing CHIKV E2-E1 antigen,and compared its immunogenicity with soluble recombinant protein s E2-E1 antigen expressed in S2 cells.For comparison,we first showed that recombinant protein antigens mixed with aluminum adjuvant elicit strong antigenspecific humoral immune response and a moderate cellular immune response in C57BL/6 mice.Moreover,s E2-E1vaccine stimulated 12-23 folds more neutralizing antibodies than s E1 vaccine and s E2 vaccine.Significantly,when E2-E1 gene was delivered by an m RNA-LNP vaccine,not only the better magnitude of neutralizing antibody responses was induced,but also greater cellular immune responses were generated,especially for CD8+T cell responses.Moreover,E2-E1-LNP induced CD8~+T cells can perform cytotoxic effect in vivo.Considering its better immunogenicity and convenience of preparation,we suggest that more attention should be placed to develop CHIKV E2-E1-LNP m RNA vaccine.展开更多
Objective: To investigate the therapeutic efficacy of andrographolide, a plant derived compound, against chikungunya virus(CHIKV) infection. Methods: Using flow cytometry and immunoblotting assay, in vitro viral prote...Objective: To investigate the therapeutic efficacy of andrographolide, a plant derived compound, against chikungunya virus(CHIKV) infection. Methods: Using flow cytometry and immunoblotting assay, in vitro viral protein expression was studied in THP-1 cells line. In Balb/c mouse neonates, viral RNA copy number was determined by real time PCR. Results:The results showed reduced CHIKV protein expression on andrographolide treatment in CHIKV-infected human peripheral blood mononuclear cells, Vero cells and THP-I cell line.In vivo, andrographolide treatment to CHIKV-infected neonates reduced viral RNA copy number. Further. andrographolide also increased cytotoxic T lymphocytes both in vitro and in vivo. Andrographolide also activated host innate immune pathways, viz., protein kinase R.phosphorylated eukaryotic initiation factor 2 α, retinoic acid inducible gene-Ⅰ and interferon regulatory factor 3/7, thereby increasing IFN-a secretion. CHIKV-induced nuclear factor κlight chain enhancer of activated B cells and tumor necrosis factor-a was also reduced on andrographolide treatment. Conclusion: Andrographolide inhibits CHIKV by suppressing viral protein expression and up-regulating host innate immunity and hence could be an effective therapeutic agent against CHIKV infection.展开更多
Objective:To describe the prognostic and clinical profile of hospitalized patients with chikungunya virus(CHIKV)infection focusing on renal outcomes.Methods:This is a cross-sectional study including all patients with ...Objective:To describe the prognostic and clinical profile of hospitalized patients with chikungunya virus(CHIKV)infection focusing on renal outcomes.Methods:This is a cross-sectional study including all patients with confirmed chikungunya fever(CHIKF)admitted to 3 different highcomplexity hospitals in Fortaleza,Brazil between January 2016 and June 2017.Data analysis was carried out to evaluate correlation between clinical profile and outcomes.Results:Fifty-five patients were included,with a median age of 77(IQR=21)years,and 23(41.82%)were male.Twenty-five patients(45.45%,25/55)developed acute kidney injury(AKI),and 15(60.00%,15/25)were classified as KDIGO 1,1(4.00%)as KDIGO 2,and 9(36.00%)as KDIGO 3.The overall mortality was 34.54%whilst AKI-related mortality was 64.00%(16/25).Both AKI and encephalitis were associated with higher mortality.Patients who died were significantly older[82(IQR=12)years vs.70(IQR=28.75)years,P<0.001].In the multivariate analysis,abdominal pain was associated with an increased risk of severe AKI(OR=5.33,95%CI=1.11–25.64,P=0.037)and AKI was an independent risk factor of death(OR=12.06,95%CI=2.55–57.15,P=0.002).Recovery of renal function was similar among the different age groups.Conclusions:AKI is present in half of the study population and is an independent risk factor of death.Thus,renal function should be carefully monitored in hospitalized patients with CHIKV infection.展开更多
In this paper, a deterministic mathematical model for Chikungunya virus (Chikv) transmission and control is developed and analyzed to underscore the effect of vaccinating a proportion of the susceptible human, and ver...In this paper, a deterministic mathematical model for Chikungunya virus (Chikv) transmission and control is developed and analyzed to underscore the effect of vaccinating a proportion of the susceptible human, and vertical transmission in mosquito population. The disease free, and endemic equilibrium states were obtained and the conditions for the local and global stability or otherwise were given. Sensitivity analysis of the effective reproductive number,?Rc?(the number of secondary infections resulting from the introduction of a single infected individual into a population where a proportion is fairly protected) shows that the recruitment rate of susceptible mosquito (ΛM) and the proportion of infectious new births from infected mosquito (β)?are the most sensitive parameters. Bifurcation analysis of the model using center manifold theory reveals that the model undergoes backward bifurcation (coexistence of disease free and endemic equilibrium when Rc?< 1 ). Numerical simulation of the model shows that vaccination of susceptible human population with imperfect vaccine will have a positive impact and that vertical transmission in mosquito population has a negligible effect. To the best of our knowledge, our model is the first to incorporate vaccinated human compartment and vertical transmission in (Chikv) model.展开更多
In recent decades, the issue of emerging and reemerging infectious diseases, especially those related to viruses, has become an increasingly important area of concern in public health. It is of significance to anticip...In recent decades, the issue of emerging and reemerging infectious diseases, especially those related to viruses, has become an increasingly important area of concern in public health. It is of significance to anticipate future epidemics by accumulating knowledge through appropriate research and by monitoring their emergence using indicators from different sources. The objective is to alert and respond effectively in order to reduce the adverse impact on the general populations. Most of the emerging pathogens in humans originate from known zoonosis. These pathogens have been engaged in long-standing and highly successful interactions with their hosts since their origins are exquisitely adapted to host parasitism. They developed strategies aimed at:(1) maximizing invasion rate;(2) selecting host traits that can reduce their impact on host life span and fertility;(3) ensuring timely replication and survival both within host and between hosts; and(4) facilitating reliable transmission to progeny. In this context, Arboviruses(or ARthropod-BOrne viruses), will represent with certainty a threat for the coming century. The unprecedented epidemic of Chikungunya virus which occurred between 2005 and 2006 in the FrenchReunion Island in the Indian Ocean, followed by several outbreaks in other parts of the world, such as India and Southern Europe, has attracted the attention of medical and state authorities about the risks linked to this re-emerging mosquito-borne virus. This is an excellent model to illustrate the issues we are facing today and to improve how to respond tomorrow.展开更多
基金supported by Health Commission of Sichuan Province Medical Science and Technology Program(Grant No:24WSXT041).
文摘Objective:To systematically review the safety of different types of chikungunya vaccines in human populations.Methods:This study retrieved randomized controlled trials(RCTs)reporting on the safety of chikungunya vaccines in human populations through electronic searches of the Web of Science,PubMed,EMbase,and Cochrane Library databases.Two reviewers independently performed literature screening,data extraction,and risk of bias assessment for the included studies.Meta-analysis was conducted using STATA 18.0 software.Results:A total of eight RCTs involving 9336 subjects were included in this study.Meta-analysis showed that three out of the five chikungunya vaccines(VLA1553,mRNA-1388,and PXVX0317)exhibited favorable safety profiles,with no significant increase in the incidence of serious adverse events.The vaccine group had a higher incidence of any adverse events[risk ratio(RR)=1.26,P<0.001]and any systemic adverse events(RR=1.18,P=0.010)compared to the placebo group.The incidence of local adverse events was also higher in the vaccine group(RR=2.09,P<0.001).However,there were no significant differences between the two groups in the incidences of erythema(RR=1.41,P=0.402),headache(RR=1.14,P=0.457),or arthralgia(RR=1.45,P=0.660).Conclusions:Current evidence supports that chikungunya vaccines have a favorable safety profile.However,due to limitations in the number and quality of included studies,further high-quality research is needed to validate these conclusions.
文摘Chikungunya virus(CHIKV)infection in humans causing severe musculoskeletal pain,fever and rashes,is transmitted by the bite of infected mosquitoes,primarily Aedes(Ae.)aegypti and Ae.albopictus.CHIKV has resulted in 18.7 million cases worldwide till 2020 and after 2004 has spread to Europe,Middle East(Saudi Arabia,Pakistan,Yemen,Egypt,Oman,Iraq,Kuwait,and Iran)and Pacific regions.This rapid spread of CHIKV emphasizes the pivotal need of enforcing control measures and examining new diagnostic methods.As the mosquito vectors(Aedes)of CHIKV are evolving,vector control methods are losing its efficacy.Further,existing serological and molecular assays to detect CHIKV show variabilities in sensitivity and specificity,leading to mis-reporting or under-reporting of CHIKV cases in affected regions.In this review article,we start by discussing CHIKV infection,followed by an introduction to currently available control and detection methods.We further highlight the challenges these methods pose and how they can be conquered by employing various easy and sustainable strategies.This review may provide valuable information for the development of novel diagnostic strategies in resource limited settings for mitigating CHIKV disease.
文摘Chikungunya,a vector-borne viral disease,has become a critical global health issue due to its capacity for widespread outbreaks,especially in tropical and subtropical regions,and its recent global expansion.The resurgence of Chikun-gunya virus(CHIKV)in Karachi,Pakistan,has amplified public health challen-ges,driven by factors such as urbanization,climate change,and socioeconomic vulnerabilities,including limited healthcare infrastructure.Clinically,the disease primarily manifests with fever,rash,and debilitating joint pain,which often leads to prolonged discomfort and decreased quality of life.However,emerging evi-dence points to atypical and severe complications affecting the neurological,cardiac,and kidney systems,increasing the risk of mor-bidity and mortality.Kidney involvement in Chikungunya is of particular concern,with acute kidney injury being identified as a critical complication.Timely diagnosis of the infection and early identification of individuals at heigh-tened risk of progressing to severe kidney dysfunction is crucial to improving patient outcomes.Such individuals often include those with pre-existing kidney conditions or other underlying comorbidities,making them more susceptible to complications.This narrative review aims to synthesize and expand upon the current understanding of the me-chanisms underlying CHIKV-induced kidney injury.These mechanisms en-compass direct viral invasion of kidney tissue,immune-mediated inflammatory responses that inadvertently damage the kidneys,and the aggravation of pre-existing kidney pathologies.Furthermore,the complex interplay between the virus and the host's immune system may exacerbate kidney complications,high-lighting the multifaceted nature of CHIKV pathophysiology.
基金Ongoing Research Funding program(ORF-2025-1404),King Saud University,Riyadh,Saudi Arabia。
文摘Chikungunya is a mosquito-borne viral infection caused by the chikungunya virus(CHIKV).It is characterized by acute onset of high fever,severe polyarthralgia,myalgia,headache,and maculopapular rash.The virus is rapidly spreading and may establish in new regions where competent mosquito vectors are present.This research analyzes the regulatory dynamics of a stochastic differential equation(SDE)model describing the transmission of the CHIKV,incorporating seasonal variations,immunization efforts,and environmentalffuctuations modeled through Poisson random measure noise under demographic heterogeneity.The model guarantees the existence of a global positive solution and demonstrates periodic dynamics driven by environmental factors.A key contribution of this study is the formulation of a stochastic threshold parameter,R0L,which characterizes the conditions for disease persistence or extinction under random environmental inffuences.Although our analysis highlights age-speciffc heterogeneities to illustrate differential transmission risks,the framework is general and can incorporate other vulnerable demographic groups,ensuring broader applicability of the results.Using the Monte Carlo Markov Chain(MCMC)method,we estimate R0L=1.4978(95%C-I:1.4968–1.5823)based on CHIKV data from Florida,USA,spanning 2005 to 2017,suggesting that the outbreak remains active and requires targeted control strategies.The effectiveness of immunization,screening,and treatment strategies varies depending on the prioritized demographic groups,due to substantial differences in CHIKV incidence across age categories in the USA.Numerical simulations were conducted using the truncated Euler–Maruyama method to robustly capture the stochastic dynamics of CHIKV transmission with Poissondriven jumps.Employing an iterative approach and assuming mild convexity conditions,we formulated and solved a parameterized near-optimality problem using the Ekeland variational principle.Ourffndings indicate that vaccination campaigns are signiffcantly more effective when focused on vulnerable adults over the age of 66,as well as individuals aged 21 to 25.Furthermore,enhancements in vaccine effcacy,diagnostic screening,and treatment protocols all contribute substantially to minimizing infection rates compared to current standard approaches.These insights support the development of targeted,age-speciffc public health interventions that can signiffcantly improve the management and control of future CHIKV outbreaks.
文摘Rationale:Parsonage-Turner syndrome is a rare syndrome of unknown etiology,affecting mainly the lower motor neurons of the brachial plexus.Chikungunya fever is a mosquito-borne viral disease characterized by acute fever and polyarthritis/polyarthralgia.Patient concerns:A 54-year-old Brazilian male patient who presented with a 2-day history of fever(temperature 38.8℃),arthralgia,erythematous rash,diffuse osteomuscular pain and headache,which evolved into left shoulder pain associated with morning stiffness.Diagnosis:Parsonage-Turner syndrome and chikungunya fever.Interventions:Symptomatic treatment(a combination of short-acting dypirone(500 mg every 6 h)and slow-release opioids(tramadol 100 mg every 4 h)and physiotherapy/rehabilitation with improvement.Outcomes:The patient was improved and discharged,remaining with symptomatic treatment and physiotherapy/rehabilitation.Lessons:To the best of our knowledge,there were no reports of Parsonage-Turner syndrome following chikungunya virus infection.Awareness of the possibility of this rare association is important.The present case report highlights the importance of awareness of this association as a new cause of morbidity in patients with chikungunya virus infection.
文摘Objective:To obtain Iuteolin and apigenin rich fraction from the ethanolic extract of Cynodon dactylon(L.)(C.dactylon) Pers and evaluate the fraction's cytotoxicity and anti-Chikungunya potential using Vero cells.Methods:The ethanolic extract of C.dactylon was subjected to silica gel column chromatography to obtain anti-chikungunya virus(CHIKV) fraction.Reverse phase-HPLC and GC-MS studies were carried out to identily the major phytochemicals in the fraction using phylochemical standards.Cytotoxicity and the potential of the fraction against CHIKV were evaluated in vitro using Vero cells.Reduction in viral replication was assessed by reverse transcriptase-polymerase chain reaction(RT-PCR) after treating the viral infected Vero cells with the fraction.Results:Reverse Phase-HPLC and GC-MS studies confirmed the presence of flavonoids,luteolin and apigenin as major phytochemicals in the anti-CHIKV ethanolic fraction of C.dactylon- The fraction was found to exhibit potent viral inhibitory activity(about 98%) at the concentration of 50 μg/mL as observed by reduction in cytopathic effect,and the cytotoxic concentration of the fraction was found to be 250 μg/mL.RT-PCR analyses indicated that the reduction in viral mRNA synthesis in fraction treated infected cells was much higher than the viral infected control cells.Conclusions:Luteolin and apigenin rich ethanolic fraction from C.dactylon can be utilized as a potential therapeutic agent against CHIKV infection as the fraction does not show cytotoxicity while inhibiting the virus.
基金The Department of Biotechnology,Bharathiar University,Coimbatore,Tamil Nadu,India for supporting this research through DST-FIST (SR/FST/LST-299/2006 Dt:31-01-2007)UGC-SAP (F.No.3-9/2007 (SAP-II) February 2007)
文摘Infectious diseases are indeed a lifelong threat to everyone irrespective of age, sex, lifestyle and socio-economic status. The infectious diseases have persisted among the prominent causes of death globally. Recently, re-emergence of Chikungunya viral infection harmed many in Asian and African countries. Chikungunya was considered as a major threat in developing and underdeveloped countries; the recent epidemiological outbreak of Chikungunya in La Reunion urges the global researchers to develop effective vaccine against this viral disease. In this review, Chikungunya, pathogenesis and epidemiology were briefly described.
基金supported by the Center of Excellence in Clinical Virology.Chulalongkorn University,CU Centenary Academic Development ProjectKing Chulalongkorn Memorial Hospital,the National Research University Project of CHEthe Ratchadaphiseksonphot Endowment Fund(HR1155A)
文摘Objective:To develop diagnostic test for detection chikungunya virus(CHIKV and Dengue virus (DENV) infection.Methods:We have performed a rapid,accurate laboratory confirmative method to simultaneously detect,quantify and differentiate CHIKV and DENV infection by single-step multiplex real-time RT-PCR.Results:The assay’s sensitivity was 97.65%,specificity was 92.59% and accuracy was 95.82%when compared to conventional RT-PCR.Additionally,there was no cross-reaction between CHIKV,DENV,Japanese encephalitis virus,hepatitis C,hepatitis A or hepatitis E virus.Conclusions:This rapid and reliable assay provides a means for simultaneous early diagnosis of CHIKV and DENV in a single-step reaction.
基金supported in part by the National Key Program Project Grant from MOST #2016YFC1201000
文摘Chikungunya virus(CHIKV) is an arbovirus transmitted by Aedes mosquitos in tropical and subtropical regions across the world. After decades of sporadic outbreaks, it re-emerged in Africa,Asia, India Ocean and America suddenly, causing major regional epidemics recently and becoming a notable global health problem. Infection by CHIKV results in a spectrum of clinical diseases including an acute self-limiting febrile illness in most individuals, a chronic phase of recurrent join pain in a proportion of patients, and long-term arthralgia for months to years for the unfortunate few. No specific anti-viral drugs or licensed vaccines for CHIKV are available so far. A better understanding of virus-host interactions is essential for the development of therapeutics and vaccines. To this end, we reviewed the existing knowledge on CHIKV's epidemiology, clinical presentation, molecular virology, diagnostic approaches, host immune response, vaccine development, and available animal models. Such a comprehensive overview, we believe, will shed lights on the promises and challenges in CHIKV vaccine development.
文摘Objective:To investigate the efficacy of ethanolic extract of nilavembu kudineer choornam (EENKC) in inflammation,pain and fever using animal models to support its actions.Methods: Acute toxicity study of EENKC was performed in mice to fix the effective dose.The antipyretic, anti-inflammatory and analgesic activity of EENKC was evaluated in brewer’s yeast induced pyrexia in rats,carrageenan-induced inflammation in rats and acetic-acid induced writhing in mice model.Results:Acute toxicity revealed that EENKC didn’t show death and toxic signs up to 2 000 mg/kg.In brewer’s yeast induced pyrexia and carrageenan-induced inflammation EENKC at the doses of 200 and 400 mg/kg inhibited fever and inflammation significantly(P【0.01 and【0.05) compared to control animals.In mice,the number of writhing induced by acetic-acid was significantly(P【0.01) reduced after treatment with both the dose of EENKC than control animals. EENKC 200 mg/kg inhibits inflammation higher level in carrageenan-induced paw edema,but there is no significant difference when compared to indomethacin 10 mg/kg.Conclusions:The present findings revealed that EENKC possesses antipyretic,anti-inflammatory and analgesic activity which supports nilavembu kudineer choornam efficacy in chikungunya fever.
基金supported by Grants from the R&D Convergence Program of National Research Council of Science & Technology (No. CAP-16-02-KIST)the National Research Foundation of Korea (No. NRF-2016M3A9B6918584)
文摘Chikungunya fever is a vector-borne viral disease transmitted to humans by chikungunya virus(CHIKV)-infected mosquitoes.There have been many outbreaks of CHIKV infection worldwide,and the virus poses ongoing risks to global health.To prevent and control CHIKV infection,it is important to improve the current CHIKV diagnostic approaches to allow for the detection of low CHIKV concentrations and to correctly distinguish CHIKV infections from those due to other mosquito-transmitted viruses,including dengue virus(DENV),Japanese encephalitis virus(JEV),and Zika virus(ZIKV).Here,we produced monoclonal antibodies(mAbs)against the CHIKV envelope 2 protein(CHIKV-E2)and compared their sensitivity and specificity with commercially available mAbs using enzyme-linked immunosorbent assays(ELISA).Two anti-CHIKV-E2 mAbs,19-1 and 21-1,showed higher binding affinities to CHIKV-E2 protein than the commercial mAbs did.In particular,the 19-1 mAb had the strongest binding affinity to inactivated CHIKV.Moreover,the 19-1 mAb had very little cross-reactivity with other mosquito-borne viruses,such as ZIKV,JEV,and DENV.These results suggest that the newly produced anti-CHIKV-E2 mAb,19-1,could he used for CHIKV diagnostic approaches.
基金supported by the Science and Technology Basic Work Program(2013FY113500)from the Ministry of Science and Technology of Chinathe International Cooperation on key Technologies of Biosafety along the China-Pakistan Economic Corridor(153B42KYSB2017 0004)+1 种基金the Strategic Bio-resource Service Network Plan and Building the Biogenetic Resource Preserving Capacity Program from the Chinese Academy of Sciences(ZSSB-002)funded by the National Basic Scientific Data Sharing-Service Platform(XXH12504-3-15)
文摘Chikungunya virus(CHIKV) is a mosquito-borne virus that causes epidemics widely in the world especially in the tropical and subtropical regions. Phylogenetic analysis has found that the CHIKV lineages were associated with the spatial and temporal distributions, which were related to the virus adaption to the major mosquito species and their distributions. In this study, we reported the complete genome sequences of eight CHIKV isolates from the outbreak in Pakistan last year. Then we reviewed the evolutionary history using extensive phylogenetic analysis, analyzed lineagespecific substitutions in viral proteins, and characterized the spreading pathway of CHIKV strains including the Pakistani strains. The results showed that the Pakistani stains belonged to the ECSA.IOL sub-lineage and derived from India. The genetic properties of the Pakistani strains including the adaptive substitution to vectors were further characterized, and the potential risks from the occurrence of CHIKV infection in Pakistan were discussed. These results provided better understanding of CHIKV evolution and transmission in the world and revealed the possible origination of the CHIKV outbreak and epidemic in Pakistan, which would promote the disease prevention and control in the identified countries and territories with the history of CHIKV infections as well as new regions with potential risk of CHIKV outbreaks.
基金supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HR1155A)Thailand Research Fund (DPG5480002)the Commission on Higher Education, Ministry of Education, and the Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project
文摘Objective: To investigate cytokine profile in patients with chikungunya virus (CHIKV) infection. Methods: Twenty eight pairs of serum samples collected from CHIKV infected patients during the outbreak of chikungunya fever in South Thailand in 2008 were obtained. A multiple cytokine assay for detection of 17 cytokines was performed. Results: In the acute stage of CHIKV infection, the patients had significantly higher levels of interleukin-6, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, monocyte chemotactic protein 1 and tumor necrosis factor alpha than the control ( P<0.001, P=0.023, P=0.015, P <0.001 and P=0.024, respectively). When the disease developed to the recovery stage, the patients had significantly lower levels of interleukin-6, granulocyte-macrophage colony-stimulating factor, monocyte chemotactic protein 1 and macrophage inflammatory protein beta than in the acute stage ( P<0.001). Conclusions: This study provides additional information that these cytokines could play roles in pathogenesis of CHIKV infection and could be used as disease biomarkers or drug targets.
文摘Objective: To investigate the association between TLR3 and TLR7 polymorphisms with susceptibility and clinical manifestations of Chikungunya Fever.Methods: A total of 177 individuals were studied: 73 patients with a confirmed diagnosis for Chikungunya virus and 104 non-infected individuals. Polymorphisms were determined by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism(PCR-RFLP).Results: Our analysis showed an increased CC genotype frequency of the TLR7 rs3853839 polymorphism in male patients compared to control(29% versus 2%,respectively; OR=20.69; 95% CI=2.55-167.36; P<0.001). Furthermore,arthritis(acute and chronic) was frequently found in CC male patients. On the contrary,65% of CG carriers were no-infected males(29% versus 65%,respectively; OR=0.23,95% CI=0.48-3.04; P=0.002). Finally,we observed a higher frequency of lymphopenia in CG male patients(CG=666.86±233.77,GG=1,314.27±752.29 cells/mm3,P=0.047). Conclusions: Our results suggest the TLR7 rs3853839 polymorphism is associated with lymphopenia and increased susceptibility to Chikungunya Fever in males.
基金supported by the Department of Biotechnology,Bharathiar University,Coimbatore,Tamil Nadu,India through DST-FIST,UGC-SAP and UKIERI
文摘A number of re-emerging and emerging infectious diseases including chikungunya, West Nile, yellow fever, Zika, dengue, Japanese encephalitis, and others have increased in recent years, which threaten the public health across the globe. Chikungunya is a neglected re-emerging arboviral infection caused by chikungunya virus. Arboviral infections such as chikungunya, Zika and dengue have similar epidemiology, transmission cycles and clinical symptoms, which makes it difficult to diagnose these three infections. Moreover, there is no commercial vaccine or licensed therapy available for chikungunya infection, thus causing severe burden worldwide. Vector control may reduce the disease risk; however, this remains a challenge due to many factors including, but not limited to, evolution of insecticide resistance in mosquitoes, gaps in vector control tools, urbanization, environmental and demographic changes. Effective integrated vector control strategies and surveillance measures along with affordable vaccine development or anti-viral therapy are essential to control the infection. In this review, we discuss the epidemiology of mosquito-borne infection chikungunya which has re-emerged as an international concern in recent decades.
基金supported by the following grants:the National Key R&D Program of China(Grant 2016YFC1201000 to X.J.)the Institute Fund of Shanghai Public Health Clinical Center(Grant KY-GW-2021-17 to ZH.L.)。
文摘Arthropod-borne chikungunya virus(CHIKV)infection can cause a debilitating arthritic disease in human.However,there are no specific antiviral drugs and effective licensed vaccines against CHIKV available for clinical use.Here,we developed an m RNA-lipid nanoparticle(m RNA-LNP)vaccine expressing CHIKV E2-E1 antigen,and compared its immunogenicity with soluble recombinant protein s E2-E1 antigen expressed in S2 cells.For comparison,we first showed that recombinant protein antigens mixed with aluminum adjuvant elicit strong antigenspecific humoral immune response and a moderate cellular immune response in C57BL/6 mice.Moreover,s E2-E1vaccine stimulated 12-23 folds more neutralizing antibodies than s E1 vaccine and s E2 vaccine.Significantly,when E2-E1 gene was delivered by an m RNA-LNP vaccine,not only the better magnitude of neutralizing antibody responses was induced,but also greater cellular immune responses were generated,especially for CD8+T cell responses.Moreover,E2-E1-LNP induced CD8~+T cells can perform cytotoxic effect in vivo.Considering its better immunogenicity and convenience of preparation,we suggest that more attention should be placed to develop CHIKV E2-E1-LNP m RNA vaccine.
基金Defence Research & Development Organmzation (DRDO)is gratefully acknowledged for the financial support in the form NBC subproject
文摘Objective: To investigate the therapeutic efficacy of andrographolide, a plant derived compound, against chikungunya virus(CHIKV) infection. Methods: Using flow cytometry and immunoblotting assay, in vitro viral protein expression was studied in THP-1 cells line. In Balb/c mouse neonates, viral RNA copy number was determined by real time PCR. Results:The results showed reduced CHIKV protein expression on andrographolide treatment in CHIKV-infected human peripheral blood mononuclear cells, Vero cells and THP-I cell line.In vivo, andrographolide treatment to CHIKV-infected neonates reduced viral RNA copy number. Further. andrographolide also increased cytotoxic T lymphocytes both in vitro and in vivo. Andrographolide also activated host innate immune pathways, viz., protein kinase R.phosphorylated eukaryotic initiation factor 2 α, retinoic acid inducible gene-Ⅰ and interferon regulatory factor 3/7, thereby increasing IFN-a secretion. CHIKV-induced nuclear factor κlight chain enhancer of activated B cells and tumor necrosis factor-a was also reduced on andrographolide treatment. Conclusion: Andrographolide inhibits CHIKV by suppressing viral protein expression and up-regulating host innate immunity and hence could be an effective therapeutic agent against CHIKV infection.
文摘Objective:To describe the prognostic and clinical profile of hospitalized patients with chikungunya virus(CHIKV)infection focusing on renal outcomes.Methods:This is a cross-sectional study including all patients with confirmed chikungunya fever(CHIKF)admitted to 3 different highcomplexity hospitals in Fortaleza,Brazil between January 2016 and June 2017.Data analysis was carried out to evaluate correlation between clinical profile and outcomes.Results:Fifty-five patients were included,with a median age of 77(IQR=21)years,and 23(41.82%)were male.Twenty-five patients(45.45%,25/55)developed acute kidney injury(AKI),and 15(60.00%,15/25)were classified as KDIGO 1,1(4.00%)as KDIGO 2,and 9(36.00%)as KDIGO 3.The overall mortality was 34.54%whilst AKI-related mortality was 64.00%(16/25).Both AKI and encephalitis were associated with higher mortality.Patients who died were significantly older[82(IQR=12)years vs.70(IQR=28.75)years,P<0.001].In the multivariate analysis,abdominal pain was associated with an increased risk of severe AKI(OR=5.33,95%CI=1.11–25.64,P=0.037)and AKI was an independent risk factor of death(OR=12.06,95%CI=2.55–57.15,P=0.002).Recovery of renal function was similar among the different age groups.Conclusions:AKI is present in half of the study population and is an independent risk factor of death.Thus,renal function should be carefully monitored in hospitalized patients with CHIKV infection.
文摘In this paper, a deterministic mathematical model for Chikungunya virus (Chikv) transmission and control is developed and analyzed to underscore the effect of vaccinating a proportion of the susceptible human, and vertical transmission in mosquito population. The disease free, and endemic equilibrium states were obtained and the conditions for the local and global stability or otherwise were given. Sensitivity analysis of the effective reproductive number,?Rc?(the number of secondary infections resulting from the introduction of a single infected individual into a population where a proportion is fairly protected) shows that the recruitment rate of susceptible mosquito (ΛM) and the proportion of infectious new births from infected mosquito (β)?are the most sensitive parameters. Bifurcation analysis of the model using center manifold theory reveals that the model undergoes backward bifurcation (coexistence of disease free and endemic equilibrium when Rc?< 1 ). Numerical simulation of the model shows that vaccination of susceptible human population with imperfect vaccine will have a positive impact and that vertical transmission in mosquito population has a negligible effect. To the best of our knowledge, our model is the first to incorporate vaccinated human compartment and vertical transmission in (Chikv) model.
基金Institutional funds from the Centre National de la Recherche Scientifique
文摘In recent decades, the issue of emerging and reemerging infectious diseases, especially those related to viruses, has become an increasingly important area of concern in public health. It is of significance to anticipate future epidemics by accumulating knowledge through appropriate research and by monitoring their emergence using indicators from different sources. The objective is to alert and respond effectively in order to reduce the adverse impact on the general populations. Most of the emerging pathogens in humans originate from known zoonosis. These pathogens have been engaged in long-standing and highly successful interactions with their hosts since their origins are exquisitely adapted to host parasitism. They developed strategies aimed at:(1) maximizing invasion rate;(2) selecting host traits that can reduce their impact on host life span and fertility;(3) ensuring timely replication and survival both within host and between hosts; and(4) facilitating reliable transmission to progeny. In this context, Arboviruses(or ARthropod-BOrne viruses), will represent with certainty a threat for the coming century. The unprecedented epidemic of Chikungunya virus which occurred between 2005 and 2006 in the FrenchReunion Island in the Indian Ocean, followed by several outbreaks in other parts of the world, such as India and Southern Europe, has attracted the attention of medical and state authorities about the risks linked to this re-emerging mosquito-borne virus. This is an excellent model to illustrate the issues we are facing today and to improve how to respond tomorrow.
